Results 251 to 260 of about 1,214,779 (339)

Design and Validation of a Predictive Model for Hepatocellular Carcinoma Based on Genes With Differential Expression Driven by DNA Methylation

open access: yesInternational Journal of Genomics, Volume 2026, Issue 1, 2026.
Background Hepatocellular carcinoma (HCC) ranks among the world′s most lethal cancers, with the majority of cases diagnosed at advanced stages. Accurate prognostic assessment is therefore essential for HCC management. This study utilized DNA methylation (MDGs) and RNA‐sequencing data to develop and validate a predictive model for HCC.
Geyang Hu   +3 more
wiley   +1 more source

Systematic Analysis of Peripheral Immune Signatures and Diagnostic Model Construction in Patients With Uterine Fibroids

open access: yesJournal of Immunology Research, Volume 2026, Issue 1, 2026.
Objective To systematically characterize the peripheral immune signature of uterine fibroids (UFs) and to develop a diagnostic model for differentiating UF patients from healthy individuals, thereby providing new insights into UF immunopathogenesis.
Pei-Xian Li   +5 more
wiley   +1 more source

Percutaneous Transhepatic Retrieval of Dysfunctional Plastic Biliary Stents

open access: yesRadiology Research and Practice, Volume 2026, Issue 1, 2026.
Purpose To evaluate the safety and efficacy of percutaneous transhepatic retrieval of dysfunctional plastic biliary stent (PBS). Materials and Methods In this retrospective, single‐center study, clinical and procedural data of 36 patients who underwent percutaneous transhepatic retrieval of dysfunctional PBS between January 2015 and April 2021 were ...
Milan Sigdel   +9 more
wiley   +1 more source

Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a dismal prognosis, largely because of late‐stage diagnosis and therapeutic resistance. PDAC incidence has been rising, with modifiable and non‐modifiable risk factors contributing to disease development.
Alessandro Mannucci, Ajay Goel
wiley   +1 more source

Home - About - Disclaimer - Privacy